934 related articles for article (PubMed ID: 16120633)
1. Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
3. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
4. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
5. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Jullien V
Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
[TBL] [Abstract][Full Text] [Related]
7. Systemic antifungal drugs.
Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
[No Abstract] [Full Text] [Related]
8. The current role of amphotericin B lipid complex in managing systemic fungal infections.
Chu P; Sadullah S
Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
[TBL] [Abstract][Full Text] [Related]
9. Current and future therapy of invasive fungal infections.
Andriole VT
Curr Clin Top Infect Dis; 1998; 18():19-36. PubMed ID: 9779349
[TBL] [Abstract][Full Text] [Related]
10. [Systemic antifungals. Pharmacodynamics and pharmacokinetics].
Catalán M; Montejo JC
Rev Iberoam Micol; 2006 Mar; 23(1):39-49. PubMed ID: 16499430
[TBL] [Abstract][Full Text] [Related]
11. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
Cuenca-Estrella M
Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554
[TBL] [Abstract][Full Text] [Related]
12. Antifungal agents in children.
Steinbach WJ
Pediatr Clin North Am; 2005 Jun; 52(3):895-915, viii. PubMed ID: 15925667
[TBL] [Abstract][Full Text] [Related]
13. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
14. [Choice and use of antifungal drugs].
Dupont B
Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
[TBL] [Abstract][Full Text] [Related]
15. [Systemic antifungal agents].
Lumbreras C; Lizasoain M; Aguado JM
Enferm Infecc Microbiol Clin; 2003; 21(7):366-79; quiz 380, 390. PubMed ID: 14525693
[TBL] [Abstract][Full Text] [Related]
16. [Commonly used antifungal agents in the treatment of systemic mycoses].
Berenguer Berenguer J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
[No Abstract] [Full Text] [Related]
17. Safety of triazole antifungal drugs in patients with cancer.
Cronin S; Chandrasekar PH
J Antimicrob Chemother; 2010 Mar; 65(3):410-6. PubMed ID: 20035021
[TBL] [Abstract][Full Text] [Related]
18. Overview of antifungal agents.
Thompson GR; Cadena J; Patterson TF
Clin Chest Med; 2009 Jun; 30(2):203-15, v. PubMed ID: 19375628
[TBL] [Abstract][Full Text] [Related]
19. [Voriconazole: a new weapon against invasive fungal infections].
Aoun M
Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
[TBL] [Abstract][Full Text] [Related]
20. Antifungal agents used for deep-seated mycotic infections.
Terrell CL; Hermans PE
Mayo Clin Proc; 1987 Dec; 62(12):1116-28. PubMed ID: 3682956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
